Improvements in Preventive Care Lacking
Executive Summary
The push to improve healthcare quality in the U.S. has been a consistent goal, imbedded in the industry for years. However, over the last decade this movement rose to a higher level of necessity, and a number of programs have been generated from within the industry as well as government agencies -- but, has significant progress been made?
You may also be interested in...
Health Care Trends (03/2007): The Case for Pay-for-Performance
The pay-for-performance (P4P) model, which allows hospitals and physicians to be compensated with higher payer reimbursement for providing documented quality care, is becoming a standard practice with a growing number of private insurers, and the federal government wants to use a P4P system for Medicare.
BMS Deals Diabetes Drugs, Solidifies Specialist Stance
The recent diabetes alliance between Bristol-Myers Squibb and AstraZeneca on two late-stage clinical compounds highlights some of the different ways pharmaceutical companies are embracing both specialty products and externalization strategies to address the industry's growing pipeline problem. BMS and AZ are pursuing different approaches but in diabetes, those strategies are complementary: AZ's unabashed externalization and muscular primary care marketing suits BMS's gradual weaning off the blockbuster model.
Satiety: Treating Obesity Beyond Quality of Life
Obesity is no longer merely a lifestyle-related condition; it's a worldwide epidemic with life-threatening consequences. Satiety is developing a device-based alternative to surgery that could expand the market for both physicians and patients.